Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday.
The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or above levels approved by the U.S. Food and Drug Administration.
Long-term ingestion of N-nitroso-varenicline may b...
Radiologists still outperform artificial intelligence (AI) when it comes to breast cancer screening, a new paper shows.
Many countries have mammography screening programs to detect and treat breast cancer early. However, examining mammograms for early signs of cancer means a lot of repetitive work for radiologists, which can result in some cancers being missed, the authors explained.
Here's another reason to avoid unnecessary use of antibiotics: Long-term use of these medications could increase your risk of colon cancer, researchers say.
"While in many cases antibiotic therapy is necessary and saves lives, in the event of less serious ailments that can be expected to heal anyway, caution should be exercised. Above all to prevent bacteria from developing resistance but...
A recall of more than a dozen types of Philips breathing machines because of potential cancer risks has millions of Americans struggling to find replacements to deal with sleep disorders, breathing problems and respiratory emergencies.
The recall involves certain Respironics BiPAP (bi-level positive air pressure), CPAP (continuous positive air pressure) and ventilator machines made before...
As legal use of marijuana expands, experts say U.S. cancer patients are still far less likely to use it than the general population.
That's the key finding from a new study based on data on smoking habits -- both tobacco and pot -- collected from nearly 20,000 people between 2013 and 2018. Several U.S. states legalized recreational pot during that time.
Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report.
The new findings are important, they noted, because immunotherapy doesn't typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once their disease no longer responds to chemotherapy.
Significant fatigue at the start of cancer treatment is associated with a greater risk of severe side effects and shorter survival, a new study finds.
Researchers analyzed data from four clinical trials of lung cancer or prostate cancer treatments that were conducted by the SWOG Cancer Research Network, a cancer clinical trials group funded by the U.S. National Cancer Institute.
An experimental gel has shown early promise in treating the most common form of skin cancer -- hinting at a potential alternative to surgery in the future.
Researchers tested the gel in 30 patients with basal cell carcinoma (BCC), a skin cancer diagnosed in more than 3 million Americans each year. The tumors rarely spread and are highly curable, usually through surgical removal.
The pandemic widely disrupted medical care across the United States, but a new study reports that clinical trials testing cancer treatments were able to carry on.
Researchers found that U.S. cancer trials quickly responded to the pandemic in the early months, allowing the studies to get back on track after an initial -- and steep -- drop-off in patient participation.
Sun protection is essential as you enjoy the outdoors this summer, a skin expert stresses.
"Skin cancer is the most common cancer in humans so it's important that we do what we can to protect ourselves," Dr. Ida Orengo, a professor of dermatology at Baylor College of Medicine in Houston, said in a school news release.
Black men in the United States have higher rates of prostate cancer than white men, yet they were far less likely to have surgery for their cancer during the first wave of the COVID-19 pandemic, a new study finds.
Researchers analyzed data from a Pennsylvania urologic database to compare prostate removal (prostatectomy) rates among Black and white patients who had untreated prostate cance...
The first full approval of a drug to treat lymphoma in dogs has been granted by the U.S. Food and Drug Administration.
"While canine lymphoma affects fewer than 70,000 dogs in the U.S. annually, it accounts for up to 24% of all cancers in dogs, making it one of the most significant canine cancers," Steven Solomon, director of the FDA's Center for Veterinary Medicine, said in an agency new...
Let's not toast to this: Alcohol was linked with 740,000 new cancer cases globally in 2020, representing 4% of all newly diagnosed cases that year, researchers say.
"Trends suggest that although there is a decrease in alcohol consumption per person in many European countries, alcohol use is on the rise in Asian countries such as China and India, and in sub-Saharan Africa," said study co-a...
The Affordable Care Act (ACA) has eased financial struggles for younger adult cancer survivors, a new study finds.
University of Michigan researchers analyzed data from more than 20,000 participants in the National Health Interview Survey and found that cancer survivors ages 18 to 64 were less likely to delay treatments and had less difficulty paying for medications or dental care from 20...
A major U.S. hospital system had a strong rebound in most cancer screening tests after a steep drop-off in the early months of the COVID-19 pandemic, a new study shows.
The findings are based on an analysis of data from the Boston-based Mass General Brigham system. Depending on the type of test, between March and June of 2020, the number of cancer screenings dropped off between 65% a...
Despite being particularly susceptible to severe COVID-19, many U.S. teen and young adult cancer survivors are wary of vaccination, a new study finds.
Cancer survivors often have weakened immune systems and are more likely to develop severe respiratory infections. That puts them at greater risk from COVID, so it's strongly recommended that they get vaccinated.
You decide to take a popular colon cancer screening test that can be performed at home, and it comes back positive. A follow-up colonoscopy is scheduled, but then you suddenly receive a large and unexpected medical bill.
That's what happened to a Missouri woman who was hit with $1,900 in medical expenses after using the popular at-home colon cancer screening test called Cologuard. <...
Robert Preidt and Robin Foster HealthDay Reporters